- Home
- PAAS vs SNN Comparison
PAAS vs SNN Comparison
Compare PAAS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAAS
- SNN
- Stock Information
- Founded
- PAAS 1994
- SNN 1856
- Country
- PAAS Canada
- SNN United Kingdom
- Employees
- PAAS N/A
- SNN N/A
- Industry
- PAAS
- SNN Industrial Specialties
- Sector
- PAAS
- SNN Health Care
- Exchange
- PAAS Nasdaq
- SNN Nasdaq
- Market Cap
- PAAS 16.5B
- SNN 15.2B
- IPO Year
- PAAS 1995
- SNN 1999
- Fundamental
- Price
- PAAS $37.40
- SNN $32.50
- Analyst Decision
- PAAS Strong Buy
- SNN Hold
- Analyst Count
- PAAS 3
- SNN 4
- Target Price
- PAAS $45.67
- SNN $32.83
- AVG Volume (30 Days)
- PAAS 5.8M
- SNN 593.1K
- Earning Date
- PAAS 11-12-2025
- SNN 10-30-2025
- Dividend Yield
- PAAS 1.23%
- SNN 2.25%
- EPS Growth
- PAAS N/A
- SNN 59.91
- EPS
- PAAS 1.73
- SNN 0.56
- Revenue
- PAAS $3,254,800,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- PAAS $21.54
- SNN $7.85
- Revenue Next Year
- PAAS $9.98
- SNN $5.43
- P/E Ratio
- PAAS $21.62
- SNN $58.35
- Revenue Growth
- PAAS 21.75
- SNN 5.35
- 52 Week Low
- PAAS $19.80
- SNN $23.69
- 52 Week High
- PAAS $42.57
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- PAAS 53.18
- SNN 31.31
- Support Level
- PAAS $36.65
- SNN $33.05
- Resistance Level
- PAAS $40.79
- SNN $33.66
- Average True Range (ATR)
- PAAS 1.31
- SNN 0.51
- MACD
- PAAS 0.40
- SNN -0.32
- Stochastic Oscillator
- PAAS 56.87
- SNN 12.92
About PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.